early detection & diagnosis of cancer
TRANSCRIPT
ancerCDiagnosis ofColorectal
Innovation
Wor
ksho
p
in PreventionEarly Detection &
June 20145th
6th
Hei
del
ber
g
INN
OVA
TIO
N IN
PR
EVEN
TIO
N, E
AR
LY D
ETEC
TIO
N &
DIA
GN
OSI
S O
F C
OLO
REC
TAL
CA
NC
ER
Hei
del
ber
g –
Ger
man
y Ju
ne 5
TH –
6TH
201
4
UniversitätsKlinikum Heidelberg
June 5th 201412:00 – 12:10 Welcome SpeechChrista Maar German Network Against Colorectal Cancer and Felix Burda Foundation, MunichOtmar D. WiestlerGerman Cancer Research Center, Heidelberg12:10 – 12:40 Key Note Speech Harald zur Hausen German Cancer Research Center, HeidelbergKey Note Speech: Links of Colorectal Cancer to Infections
Session I Innovative Approaches in Colorectal Cancer Early DetectionChair: Hermann Brenner
12:40 – 13:00 Frank KolligsHospital Großhadern, University of Munich Imaging of The Colon: State of The Art 13:00 – 13:20 John E. BlumeApplied Proteomics Inc., San Diego Using Targeted Mass Spectrometry to Identify a Plasma-BasedProtein Marker Panel for Colorectal Cancer Risk Determination 13:20 – 13:40 Markus F. NeurathUniversity Hospital, ErlangenA Pilot Study for Identification of Serum Markers for Colorectal Polyps 13:40 – 14:00 Hans Jørgen NielsenHvidovre Hospital, University of Copenhagen Development of a Screening Concept for CRC Based on Biological Markers in Blood
14:00 – 14:20 Coffee Break
14:20 – 14:40 Friedrich-Wilhelm TillerBavaria Health Center, MunichProbing of Tandem-Mass-Spectrometry as a Non-Immunochemical Reference Method for Hb Quantification in Feces14:40 – 15:00 Polly A. NewcombFred Hutchinson Cancer Research Center, SeattleNew Colorectal Cancer Precursors: From Microscope to MicroRNA 15:00 – 15:20 Hermann BrennerGerman Cancer Research Center, HeidelbergInnovative Epidemiology for Colorectal Cancer Early Detection
15:20 – 15:40 Coffee Break
Session IIAspirin in Colon Cancer PreventionChair: Cornelia Ulrich & Jürgen Riemann
15:40 – 16:00 John A. BaronCancer Hospital, University of North Carolina, Chapel HillAspirin and Vitamin D in Cancer Prevention: The Evidence Today16:00 – 16:20 Nadir ArberTel Aviv Medical Center Personal Aspirin Therapy16:20 – 16:40 Gabriela G. MösleinHELIOS St. Josefs Hospital, Bochum-LindenThe German Status of Moving Anti-Inflammatory Drugs Into the Clinic for High-Risk Individuals16:40 – 17:00 Cornelia UlrichNational Center for Tumor Diseases, HeidelbergPharmacogenetics of Aspirin and Anti-Inflammatory Agents: Moving Towards Translation Through Personalized Prevention Strategies
17:00 – 17:20 Coffee Break
Session III Immunotherapy in Colorectal CancerChair: Dirk Jäger
17:20 – 17:40 Niels HalamaNational Center for Tumor Diseases, HeidelbergThe Immunological Landscape of Metastatic Colorectal Cancer: Cells, Cytokines and Treatment Decisions17:40 – 18:00 Ugur SahinTRON Translational Oncology, University MainzGenomics Engineered Personalized Cancer Immunotherapy18:00 – 18:20 Philipp BeckhoveGerman Cancer Research Center, Heidelberg CRC Prognosis is Determined by in Situ Activity of Tumor Specific TIL18:20 – 18:40 Hans-Georg RammenseeUniversity Hospital, TuebingenPeptide-Based Immunotherapy of Cancer18:40 – 19:00 Magnus von Knebel-DoeberitzUniversity Hospital, HeidelbergThe Immune Biology of DNA Mismatch Repair Deficient Tumor Cells: Towards a Vaccine for Hereditary Colon Cancer
19:00 Welcome Reception at DKFZ
June 6th 2014
Session IVGenomics, Epigenetics and Risk Stratification of Colorectal Cancer Chair: Hanno Glimm
09:00 – 09:20 Jane C. FigueiredoUniversity of Southern CaliforniaGenome-Wide Studies of Gene-Dietary Interactions and Colorectal Cancer Risk09:20 – 09:40 Davina GaleCancer Research UK Cambridge Institute, University of Cambridge Non-Invasive Analysis of the Cancer Genome Using Circulating Tumor DNA09:40 – 10:00 Wilko Weichert National Center for Tumor Diseases & University Hospital HeidelbergColorectal Cancer Syndromes – Novel Insights10:00 – 10:20 Joachim P. SpatzMax Planck Institute for Intelligent Systems, Stuttgart and University of HeidelbergMarker-Free Phenotyping of Tumor Cells by Fractal Analysis of Optical Microscopy Image
10:20 – 10:40 Coffee Break
Session VColon MicrobiomeChair: Dirk Haller
10:40 – 11:00 Meredith A. J. HullarFred Hutchinson Cancer Research Center, SeattleThe Colon Microbiome Associated with Human Health11:00 – 11:20 Mathias Chamaillard Institut Pasteur de LilleRemote Control of Intestinal Inflammation and Tumorigenesis by the Intestinal Microbiota11:20 – 11:40 Peer BorkEuropean Molecular Biology Laboratory, HeidelbergDiagnostic Potential of Faecal Microbiota Associated with Colorectal Cancer11:40 – 12:00 Stephen J. D. O’KeefeDepartment of Medicine, University of PittsburghDiet, the Microbiome and Cancer Risk: Switching Diets between High Colon Cancer Risk Americans and Low Risk Africans12:00 – 12:20 Jiyoung AhnNew York University School of MedicineHuman Gut Microbiome, Fiber Intake, and Colorectal Cancer Risk12:20 – 12:40 Christian JobinDepartment of Medicine, University of Florida, GainesvilleInflammation is Essential for Microbial-Induced Carcinogenic Properties in the Intestine
12:40 – 13:30 Lunch Break
Session VIOncology PipelineChair: Georg Ralle & Christof von Kalle
Presentation of New Developments of the Pharmaceutical Industry 13:30 - 13:50 Uwe Phillip StraussBayer Vital GmbH, Leverkusen13:50 - 14:10 Florin SirzenF. Hofmann-La Roche, Basel14:10 - 14:30 N.N.Merck Serono GmbH, Darmstadt14:30 - 14:50 Stephan BrockMolecular Health GmbH, Heidelberg14:50 - 15:10 Bernd MüllerMSD SHARP & DOHME GMBH, Haar
15:10 – 15:30 Coffee Break
Session VIIPanel Discussion
15:30 – 17:00 Moderation: Jörg Rüdiger SiewertMedical Director & CEO Medical Center University Freiburg Participants of the Panel Discussion:Friedrich von Bohlen Managing Director,dievini Hopp BioTech holding GmbH & Co. KG, WalldorfWerner EberhardtChief Health Platform Expert, SAP AG, WalldorfMichael HallekHead of Hospital I for Internal Medicine, University of Cologne Otmar D. WiestlerChairman & Scientific Director of German Cancer Research Center, Heidelberg
UniversitätsKlinikum Heidelberg
With friendly support of:
10.000,00 €Werbemöglichkeiten, Vortrag
10.000,00 €Werbemöglichkeiten, Vortrag
10.000,00 €Werbemöglichkeiten, Vortrag
3.000,00 €Werbemöglichkeiten, Vortrag
10.000,00 €Werbemöglichkeiten, Vortrag
Hosted by:
INN
OVA
TIO
N IN
PR
EVEN
TIO
N, E
AR
LY D
ETEC
TIO
N &
DIA
GN
OSI
S O
F C
OLO
REC
TAL
CA
NC
ER
Hei
del
ber
g –
Ger
man
y Ju
ne 5
TH –
6TH
201
4
Location:
German Cancer Research Center (DKFZ)Communication Center, Lecture HallIm Neuenheimer Feld 280, 69120 Heidelberg
Site Map:
Information and Registration:
Viktoria ReinhardtPhone: +49 (0) 6221 56-350 99 Fax: +49 (0) 6221 56-5094E-mail: [email protected]
Online Registration: www.dkfz.de/ColonWorkshop
Hosted by the National Center for Tumor Diseases (NCT) Hei-delberg, the German Cancer Research Center, the Felix Burda Foundation and the German Network Against Colorectal Cancer the 2014 Workshop on Innovation in Prevention, Early Detection and Diagnosis of Colorectal Cancer will bring together academics, scientists, clinicians and leaders of the pharmaceutical industry to share innovations and to discuss and foster new developments in prevention and early detection strategies for colorectal cancer.
Colorectal cancer is not only a major public health burden, but also effectively preventable. The interdisciplinary work-shop will cover state-of-the-art research in colorectal cancer screening and early detection, prevention strategies by anti- inflammatory drugs, genomics, immunology, and gut micro-biomics. For a joint approach and optimal exchange of information, the workshop will provide the maximum amount of interaction and discussion through an exciting range of presentations.
We hope that you will join us on June 5th – 6th 2014 at our Innovation Workshop in the beautiful city of Heidelberg and strengthen our links in colorectal cancer research.
Best Regards,
Christof von KalleDirector, Translational Oncology
National Center for Tumor Diseases Heidelberg
Otmar D. WiestlerChairman and Scientific DirectorGerman Cancer Research Center
Dirk JägerDirector, Medical Oncology
National Center for Tumor Diseases Heidelberg
Georg Ralle Secretary General of German Network
Against Colorectal Cancer
Cornelia UlrichDirector, Preventive Oncology
National Center for Tumor Diseases Heidelberg
Christa MaarCEO Felix Burda FoundationPresident of German Network
Against Colorectal Cancer
ancerCDiagnosis ofColorectal
Innovation
Wor
ksho
p
in PreventionEarly Detection &
June 20145th
6th
Hei
del
ber
g